Abstract

Primary hepatic carcinoid tumor is rare and poses a challenge for diagnosis and management. We presented a case of primary hepatic carcinoid tumor in a 53-year-old female with a complaint of right upper abdominal pain. Computer tomography scans revealed a hypervascular mass in segment 4 of the liver. An ultrasonography-guided biopsy showed a carcinoid tumor. No other lesions were found by the radiological investigations. Surgery resection was performed and histopathological examination revealed a primary hepatic carcinoid tumor. Three years later, recurrence was found and transcatheter arterial chemoembolization was performed. After transcatheter arterial chemoembolization, the patient has been free of symptom and had no radiological disease progression for over 6 months. Surgical resection combination with transcatheter arterial chemoembolization is effective to offer excellent palliation.

Highlights

  • Carcinoid tumors are neoplasms that originate from the cells of neuroendocrine system, and were first characterized by Oberndorfer in 1907

  • We report a case of Primary hepatic carcinoid tumors (PHCT), and describe the clinical features and treatment of this case

  • Histological and immunohistochemistry of the tumor confirmed the findings of the biopsy and the resection line was free from tumor invasion

Read more

Summary

Background

Carcinoid tumors are neoplasms that originate from the cells of neuroendocrine system, and were first characterized by Oberndorfer in 1907. To rule out the possibility of metastatic carcinoid tumor in the liver, more investigations were performed, including upper and lower gastrointestinal series, a small bowel series and chest and abdominal CT scans. Histological and immunohistochemistry of the tumor confirmed the findings of the biopsy and the resection line was free from tumor invasion. No other lesions were found by the radiological investigations which include upper gastrointestinal endoscopy, a small bowel series, colonoscopy, chest CT and abdominal CT scans. Six months after the last TACE, the patient was free of symptom and had no radiological disease progression

Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call